James ND, Tannock I, N’Dow J, Feng F, Gillessen S, Ali SA, et al. The Lancet Commission on prostate cancer: planning for the surge in cases. Lancet. 2024;403:1683–22.

Article  PubMed  Google Scholar 

Freedland SJ, Samjoo IA, Rosta E, Lansing A, Worthington E, Niyazov A, et al. The impact of race on survival in metastatic prostate cancer: a systematic literature review. Prostate Cancer Prostatic Dis. 2023;26:461–74.

Article  PubMed  PubMed Central  Google Scholar 

Liadi Y, Campbell T, Dike P, Harlemon M, Elliott B, Odero-Marah V. Prostate cancer metastasis and health disparities: a systematic review. Prostate Cancer Prostatic Dis. 2024;27:183–91.

Article  PubMed  Google Scholar 

Odipo E, Jarhyan P, Nzinga J, Prabhakaran D, Aryal A, Clarke-Deelder E, et al. The path to universal health coverage in five African and Asian countries: examining the association between insurance status and health-care use. Lancet Glob Health. 2024;12:e123–33. https://doi.org/10.1016/S2214-109X(23)00510-7.

Article  PubMed  Google Scholar 

United Nations Department of Economic and Social Affairs, Population Division. World Population Prospects 2022 - Summary of Results. New York: United Nations; 2022. https://www.un.org/development/desa/pd/sites/www.un.org.development.desa.pd/files/wpp2022_summary_of_results.pdf.

Sharif A, Malhotra NR, Acosta AM, Kajdacsy-Balla AA, Bosland M, Guzman G, et al. The development of prostate adenocarcinoma in a transgender male to female patient: Could estrogen therapy have played a role? Prostate. 2017;77:824–8.

Article  CAS  PubMed  Google Scholar 

Ellent E, Matrana MR. Metastatic prostate cancer 35 years after sex reassignment surgery. Clin Genitourin Cancer. 2015;14:207–9.

Article  Google Scholar 

Bosland MC, Shittu OB, Ikpi EE, Akinloye O. Potential New Approaches for Prostate Cancer Management in Resource-Limited Countries in Africa. Ann Glob Health. 2023;89:14 https://doi.org/10.5334/aogh.3994.

Article  PubMed  PubMed Central  Google Scholar 

Madersbacher S, Mian C, Maier U, Simak R. Validation of a 10-minute dipstick test for serum prostate-specific antigen. Eur Urol. 1996;30:446–50.

Article  CAS  PubMed  Google Scholar 

Ashida S, Yamasaki I, Kawada C, Fukuhara H, Fukata S, Tamura K, et al. Evaluation of a rapid one-step PSA test for primary prostate cancer screening. BMC Urol. 2021;21:135 https://doi.org/10.1186/s12894-021-00903-7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Heyns CF, Naudé AM, Ahmed G, Stopforth HB, Stellmacher GA, Visser AJ. Serum prostate-specific antigen as surrogate for the histological diagnosis of prostate cancer. South Afr Med J. 2001;91:685–9.

CAS  Google Scholar 

Heyns CF, Basson J, Van der Merwe A, Zarrabi DR. Clinical (non-histological) diagnosis of advanced prostate cancer: Evaluation of treatment outcome after androgen deprivation therapy. South Afr J Surg. 2014;52:82–85.

Article  Google Scholar 

Vickers AJ, Bianco FJ, Serio AM, Eastham JA, Schrag D, Klein EA, et al. The surgical learning curve for prostate cancer control after radical prostatectomy. J Natl Cancer Inst. 2007;99:1171–7.

Article  PubMed  Google Scholar 

Liao KM, Wang YL, Chen CY. Medication utilization evaluation of androgen deprivation therapy for prostate cancer in Taiwan. Medicine. 2020;99:e23644 https://doi.org/10.1097/MD.0000000000023644.

Article  CAS  PubMed  PubMed Central  Google Scholar